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Serial Propagation of Human Endothelial Cells In Vitro
In recent years major advances in understanding vascular
endothelial-cell growth and function have been possible due to
the perfection of techniques to isolate, grow, and identify these
cells in vitro . Bovine (1, 3, 5, 11, 22, 26) and porcine (14, 31)
aortic endothelial cells are widely studied due to the relative
ease with which they can be propagated in long-term culture .
Although endothelial cells from human pulmonary arteries
and veins have been grown in culture (19, 28), umbilical veins
are the most readily available source of human large-vessel
endothelium. Methods for the isolation and primary culture of
these cells are well established (8, 9, 18) . However, attempts to
subculture the human umbilical-vein endothelial cell through
multiple passages have met with limited success . Occasionally,
up to 10 to 19 passages of HUV endothelial cells grown on
plastic dishes in 20% fetal bovine serum may be accomplished
(12, 18) but, in general, these cells cannot be grown reproduc-
ibly for more than 2 to 3 passages (8, 9, 29). Although useful
information can be gained from the study of primary cultures,
extended subculturing facilitates the collection of large quan-
tities of cells for biochemical studies and is necessary to study
cell growth properties and requirements, as well as cellular
aging in vitro .
We have previously identified a human endothelial-cell mi-
togen from extracts of bovine hypothalamus prepared at a
neutral pH (20) . The neural-derived endothelial-cell growth
factor (ECGF) is an acid- and heat-labile protein, physically
and chemically distinct from fibroblast growth factor (10),
possessing a molecular weight of - 75,000 (20) . The major
attribute of ECGF is its ability to stimulate quiescent HUV
endothelial cells to grow in culture (20) . The addition ofECGF
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ABSTRACT
￿
Human umbilical vein (HUV) endothelial cells were grown for 15 to 21 passages at
a split ratio of 1 :5 (at least 27 population doublings) on a human fibronectin (HFN) matrix in
Medium 199 supplemented with fetal bovine serum (FBS) and endothelial-cell growth factor
(ECGF) . This system also permitted the growth of HUV endothelial cells at cell densities as low
as 1 .25 cells/Cm 2 . In addition to delaying the premature senescence of HUV endothelial cells,
ECGF also reduced the serum requirement for low-density HUV endothelial-cell growth ; 2.5%
serum and ECGF yields half-maximum growth as compared to high serum controls . Significant
HUV endothelial-cell growth was also observed in medium supplemented with either ovine
hypophysectomized (HYPOX) serum, plasma-derived serum (PDS), or HYPOX-PDS in the
presence of ECGF, suggesting that neither the pituitary nor the platelet contributes to HUV
endothelial-cell growth .
to low-seed-density cultures of HUV endothelial cells in fetal
bovine serum results in a significant increase in endothelial cell
growth compared to that achieved with serum alone (20) . In
the present paper we report that the use of ECGF and fibro-
nectin sustained the replicative capacity ofHUV endothelial
cells in long-term culture .
MATERIALS AND METHODS
Preparation of Reagents
Human fibronectin (HFN) was purified from humanCohn fraction I (Revlon
Health Care Group, Tuckahoe, N. Y .) by the method ofEngvall and Ruoslahti
(6). The HFN preparation migrated as a single band on nonreduced 5% acryl-
amideSDS-PAGE (SDS-polyacrylamidegel electrophoresis) gels and was stored
at -20°C . The ECGF was prepared from bovine hypothalamus as previously
described (20). Briefly, bovine hypothalamus (Pel-Freeze Biologicals, Rogers,
Ark.) was homogenized for 3 min in 0.15M NaCl at 4°C (1 liter/1.25 kg of
tissue) . Thehomogenate was extracted at a neutralpH and low ionic strength for
I h, centrifuged, and lipid was removed by extraction with 0.4% streptomycin
sulfate (Gibco Laboratories, Grand Island Biological Co., Grand Island, N . Y.)
for 18 h at 4°C. The extract was centrifuged and the supernatant fluid stored as
a lyophilized powder at 4°C.
Fetal bovine serum (FBS) and other cell culture media and reagents were
purchased from Gibco Laboratories (Grand Island,N . Y .). Blood from normal
and hypophysectomized(HYPOX), random-bred Suffolk sheepwas used forthe
preparation ofovine whole-blood serum (WBS) . Ovine citrated plasma, obtained
by venous puncture from normal and hypophysectomized sheep (14 d post-
HYPOX), was used for the preparation ofnormal andHYPOX plasma-derived
serum (PDS) using the method ofRoss et al. (27) . Trace amounts of plasma and
platelet-derived cationic mitogens were removed by passing the PDS, HYPOX
serum, andHYPOX-PDS through a carboxymethyl Sephadex A-50 (Pharmacia
Fine Chemicals, Piscataway, N. J.) column as recommended (27) . All sera were
stored frozen at -20°C . The ovine PDS,HYPOX serum, andHYPOX-PDS were
not capable of supporting the growth of rat abdominal-aorta smooth-muscle
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eration of RAA-SM cells, the rate of RAA-SM cell growth was significantly
better in FBS.
Preparation and Maintenance of Human
Umbilical Vein (HUV) Endothelial Cells In Vitro
Primary cultures ofHUVendothelial cells grown in the absence of an HFN
matrix or ECGF supplementation were obtained from the laboratory of Dr. M.
Gimbrone (8) . These primary cultures were harvested and plated on cell-culture
dishes coated with 10 leg HFN/cm2 cell culture-dish surface area (7) and grown
in amedium comprised of Medium 199 containing 20% FBS, 100Ixg ECGF/ml,
penicillin G (10 U/ml), streptomycin (1 hg/ml), and fungizone (5 Wg/ml) . The
cultures were fed every 2-3 d until confluent . At confluence, the cells were
harvested by treatment with 0.05% trypsin-0.02%aEDTA, the trypsin was inacti-
vated by the addition of 1.25 mg of soybean trypsin inhibitor (Sigma Chemical
Co., St . Louis, Mo .), and the cells were routinely passaged at a constant 1:5 split
ratio. The endothelial cells at various passages were stored in liquid nitrogen in
the growth medium containing 10% glycerol .
Estimation of Replicative and Functional
Capacity of HUV Endothelial Cells
For two separate stains ofHUVendothelial cells, an aliquot of cell suspension
ateachharvest was used tocount trypan-blue-excluding cells ina hemocytometer.
The number of population doublings (PD) occurring between passages was
calculated according to the equation: PD= logz (CH/Cs) where CH is the number
of viable cells at harvest and Cs is the number of cells seeded. The sum of all
previous population doublings determined the cumulative population doubling
level (CPDL) at each passage . The population doubling time (PDT) was derived
using the time interval between cell seeding and harvest divided by the number
of PD for that passage .
Samples of lyophilized, conditioned medium from confluent cultures at pas-
sages 1 through 13 of one strain of HUV endothelial cells were assayed by
radioimmunoassay forhuman FactorVIII : antigen (fVIII:AGN) by Dr. L . Hoyer
(16) . Immunofluorescent staining of the HUV endothelial cells for fVIII:AGN
was performedon confluent cultures grown in 35-mm dishes. The medium was
aspirated, and the cells were washed withphosphate-buffered saline (PBS), fixed
in methanol for 5 min at -20°C, and rinsed with PBS, The cells were incubated
with a 1:40 (vol/vol) dilution of fluorescein-conjugated rabbit anti-human fvlII:
AGN (Atlantic Antibodies, Westbrook, Maine) for 45 min . The dishes were
washed three times with PBS, rinsed briefly with distilled water, and mounted
with buffered glycerol under glass cover slips . The cells were examined with a
reflected Zeiss II epiillumination system . Rat abdominal-aorta smooth-muscle
cells (36), rat promegakaryoblasts (35), rat bone marrow (cytocentrifuge slides),
andhuman umbilical cord frozen sectionsserved as positive and negative controls
for the immunofluorescence studies .
HUV Endothelial-Cell Attachment Assay
HUVendothelial cells were seeded in Medium 199 at a density of 1 .25 x 10°
cells/cm' in duplicate 35-mm cell culture dishes that had been precoated with
various concentrations ofHFN . After 10 min at 25°C, themedium was aspirated,
and Medium 199 containing 20%FBSand 100 lLg/ml ECGF was added to each
culture dish. The cells were incubated at 37°C for 2 h, at which time the culture
dishes were washed twice with Medium 199, the cells were harvested with trypsin-
EDTA, and duplicate hemocytometer cell counts were obtained . Cell culture
dishes that were not treated with HFN served as controls.
HUV Endothelial-Cell Growth Assays
All endothelial-cell growth assays were performed with HUV endothelial-cell
stock cultures between passages 3 and 11 . To ascertain the activity of ECGF, as
a function of the concentration of various sera, we seeded cells at a density of
1.25 x 10' cells/cm' in Medium 199 containing 100 hg/ml ECGF in 35-mm cell
culture dishes coated with 10,ag/cmz HFN. Cells plated in Medium 199 contain-
ing20%FBS with or without a standard preparation ofECGF served as controls.
The cell culture dishes were fed every 2-3d with the appropriate supplements,
and the assay was terminated after 10 d in culture. The cells were harvested by
trypsin-EDTA treatment, and duplicate hemocytometer counts were obtained.
Results are reported directly as themean number of viable endothelial cells per
dish ± SD .
RESULTS
Attachment and Growth of HUV Endothelial
Cells In Vitro
HUV endothelial cells attached to plastic cell culture dishes
with a plating efficiency < 10% . If the cell culture dishes were
coated with purified HFN, the plating efficiency of HUV
endothelial-cell attachment increased to - 40 and 50% after a
10-min incubation. The relationship betweenHUV endothelial
cell attachment and the concentration ofHFN is shown in Fig.
1 . These results demonstrate that 5-10 N1g/cm 2 HFN are re-
quired for maximum HUV endothelial-cell attachment .
To ascertain whether HUV endothelial cells were capable of
growth on an HFN matrix, we compared the growth of low-
seed-density (103 cells/cm') cells plated on HFN-coated cell-
culture dishes to the growth achieved on non-HFN-treated cell
culture dishes (Fig . 2) . We observed moderate endothelial cell
growth on the HFN-coated cell-culture dishes in Medium 199
supplemented with 20% FBS . In contrast, the HFN-free cell
culture dishes did not support the growth of low-seed-density
HUV endothelial-cell cultures in the presence of 20% FBS .
The addition of ECGF to cultures plated on an HFN matrix
resulted in a significant increase in endothelial-cell growth
(Fig . 2) . Although substantial growth was observed in endo-
thelial-cell cultures supplemented with 20% FBS andECGF in
the absence ofHFN, no growth was observed in the absence of
FBS or ECGF when HFN was omitted . Optimal HUV endo-
thelial-cell growth was routinely achieved in Medium 199
supplemented with 20% FBS and 100 lag/ml ECGF on an
HFN matrix (Fig. 2) .
Growth ofHUV Endothelial Cells at Clonal Cell
Density
The HFN matrix also supported the growth ofHUV endo-
thelial cells at clonal-cell seed-densities (Figs . 3 and 4A) . HUV
endothelial cells were plated into cell culture dishes precoated
with HFN (10 ,ug/cm 2 ) at cell densities of 125, 12.5, and 1.25
cells/cm2. The cells were fed every 2-3 d with Medium 199
containing 20% FBS and 1001Lg/ml ECGF . HUV endothelial-
cell colonies become visible after - 2 wk in culture . After 28 d
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FIGURE 1 HUV endothelial cell attachment as a function of the
concentration of human fibronectin (HFN) . HUV endothelial cells
(passage 5) were plated in a cell-attachment assay as described in
Materials and Methods . The HFN matrix was prepared by adding
the appropriate concentration of HFN to a 35-mm cell culture dish
containing 1 ml of Dulbecco's PBS . The culture dish was allowed to
adsorb the HFN for 10 min at room temperature, after which excess
HFN was aspirated . The HFN-coated dishes were used immediately
after preparation . The data are expressed as viable HUV endothelial-
cell numbert SD .
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￿
Effect of HFN and ECGFon HUVendothelial-celIgrowth .
HUV endothelial cells (passage 9) were seeded at a density of 1.25
X 103 cells/cm 2 on cell culture dishes in the presence and absence
of an HFN matrix (10 Wg/cm 2 ) . The cultures were fed with the
appropriate medium (ECGF), 100,ug/ml, and 20% FBS, for a period
of 10 d . The plates were washed twice with Medium 199 and either
fixed with 10% formalin and stained with 0.1% aqueous crystal violet
or the cells were treated with trypsin-EDTA and the mean viable
cell number (t SD) was determined .
FIGURE 3 Growth of HUV endothelial cells at clonal cell density .
Cell culture dishes were pretreated with 10 ,ug/cm Z HFN . HUV
endothelial cells (passage 10) were seeded in growth medium
containing Medium 199, 20% FBS, and 100 jAg ECGF/ml at seed
densities of 125, 12 .5, and 1 .25 cells/cm' . The cultures were fed
every 2-3 d with the growth medium for a period of 28 d . At this
time, the culture dishes were washed with Medium 199, fixed with
10% formalin, and stained with 0.1% aqueous crystal violet .
in culture, distinct colonies of various sizes could be observed
(Fig . 3) . It is important to note that HUV endothelial cells did
not survive in control culture dishes that were neither coated
with HFN nor supplemented with ECGF . Selected colonies
were removed by treatment with trypsin-EDTA in cloning
wells and transferred to plastic microtiter dishes pretreated
with HFN . The seed density of the transfer was - 102 HUV
endothelial cells per microtiter well. Although the endothelial
cells survived the transfer and grew in Medium 199 supple-
mented with 20% FBS and 100 fag/ml ECGF, subsequent
transfers of the confluent HUV endothelial-cell monolayer
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from the microtiter wells to 35-mm cell culture dishes (HFN-
treated) were not successful .
The Long-term Growth of HUV Endothelial
Cells
The use of HFN-coated cell culture dishes and ECGF
supplementation in Medium 199 containing 20% FBS also
permitted the long-term growth of HUV endothelial cells in
vitro . We have routinely passaged these cells from primary
isolates at a constant 1 :5 split ratio for 15-21 times before the
cultures became senescent and expired. Cultures grown without
HFN and ECGF and passaged at this density ceased to grow
beyond the second passage .
Within 7-8 d after seeding, the HUV endothelial cells had
consistently formed a confluent epithelioid monolayer as ob-
served by phase microscopy (Fig . 4B, C, D) . Cells within the
monolayer possessed characteristic single ovoid nuclei with 2-
3 prominent nucleoli and perinuclear granules . In mid to late
passage cultures, the cells were more elongated and less densely
packed at confluence (Fig . 4 C) than in early passages where
cells appeared to have a smaller attachment area and formed
a typical cobblestone pattern (Fig. 4 B). Giant, multinucleated
cells with very broad and veil-like cytoplasm began to appear
with a low incidence (one cell per 103 cells) at about passage 8
and gradually increased in number (one cell per 10 2 cells) in
later passages (Fig . 4D) . At no time did we observe smooth
musclelike cells in any ofthese cultures .
HUV endothelial cells from two strains grown from inde-
pendent primary cultures completed between 2 and 3 PD at
each passage from passage 2 to passage 15 . The CPDL for one
strain at passage 13 was 27 and for the other at passage 15 was
34. The density of cells at confluence showed a decreasing
linear relationship with the CPDL (Fig . 5A). The overall PDT
did not increase significantly with CPDL (Fig . 5 B), remaining
an average of 2.8 d ± 0.8 (SD) for the two strains of HUV
endothelial cells .
The HUV endothelial cells were positive for fVIII:AGN by
immunofluorescent staining throughout their lifespan in cul-
ture. However, in late passages there were qualitatively more
cells with fewer grains per cell (Fig . 4 F) than at early passages
where most cells were brightly stained (Fig . 4E) . The giant
HUV endothelial cells also contained the fVIII:AGN (Fig. 4 F)
at a qualitatively reduced level . The concentration of (VIII :
AGN in the conditioned medium for one of the cell strains
averaged 2.25 U/ 100 ml± 1.09 (SD) for earlypassages (passage
1-7) and 1 .80 U/100 ml ± 0.40 for later passages (passage 8-
13) . This represented a concentration of fVIII:AGN of 1 .15 ±
0.48 U/100 ml per HUV endothelial cell in early passages and
a similar level of 1.57 ± 0.39 U/100 ml per HUV endothelial
cell for late passages .
HUV Endothelial-Cell Growth in Various Sera
FBS titration curves were performed at a constant concen-
FIGURE 4
￿
Phase-contrast photomicrographs and fVIII :AGN immunofluorescent staining of HUV endothelial cells . Frames A, B, C,
and D are same magnification (x200) . (A) Colony of HUV endothelial cells (passage 10) after 3 d in culture in Medium 199
containing 20% FBS and 100 Frg ECGF/ml (1.25 X 10' cells/cm Z) . (B) Confluent monolayer of HUV endothelial cells (passage 2) .
(C) Confluent monolayer of HUV endothelial cells (passage 8) . Note the large cells (arrows) . (D) Confluent monolayer of HUV
endothelial cells (passage 18) . Note the enlarged veil-like multinucleate cell (arrow) pushing against the tightly apposed polygonal
cell . Frames E and F are same magnification . (x250) . Human anti fVIII :AGN immunofluorescence was performed as described in
Materials and Methods. (E) HUV endothelial cells (passage 8) . (F) Large multinucleated HUV endothelial cell (passage 18) . Note
qualitative difference in staining intensity between frames E and F .MACIAG ET AL
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tration ofECGF on aHFN matrix to determine the relation-
ship between HUV endothelial cell growth and the concentra-
tion of FBS. We observed considerable HUV endothelial-cell
growth in FBS concentrations as low as 5% (vol/vol) . Approx-
imately half-maximum growth was obtained in 2.5% FBS (Fig.
6) . Ovine WBS, PDS, andHYPOX serum also were capable of
supporting HUV endothelial-cell growth in the presence of
ECGF (Fig . 7) . Although the cultures supplemented with
various concentrations of serum without ECGF did survive,
the amount of HUV endothelial-cell growth in these cultures
was minimal .
The difficulty in establishing long-term cultures of HUV en-
dothelial cells grown on plastic substrates in medium contain-
ing20%serum is well recognized . Using this traditional system,
we were not able to cultivate these cells beyond the third
passage . However, we have demonstrated that HUV endothe-
lial cells can consistently propagate in long-term culture when
grown on an HFN matrix in serum-supplemented medium
containing ECGF . Under these conditions, theHUV endothe-
lial cells attain at least27 PD . A similar increase in the in vitro
life span of cells by the addition of a growth factor has been
achieved withhuman keratinocytes, which experience a signif-
icant delay in senescence when EGF is added to the culture
system (23) .
The decrease in the density of HUV endothelial cells in
confluent cultures as a function of theCPDL is consistent with
our qualitative observations by phase microscopy of a greater
cell attachment area in later passages . These observations
suggest that the HUV endothelial cells were either becoming
broader or actually increasing in volume as a function of in
vitro age . A decrease in confluent cell density with increasing
age has also been demonstrated in bovine fetal aortic endothe-
lial cells for which ameasured increase in cell attachment area
corresponds to larger cell volumes in older populations (26) .
The increasing frequency of extremely largeHUV endothelial
cells at later passages probably accounts for much of the
decrease in confluent cell density in our older cultures .
Although the late-passageHUVendothelial cells maintained
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FIGURE 5 Growth characteristics of HUV endothelial cells in long-term culture . Stock cultures of two cell strains (+, x) were
passaged at a constant split ratio of 1 :5 as described . (A) Cell density at confluence CPDL . The data were fitted by the method of
least squares to the equation : cell density at confluence = 0.39 (t 0.04) - 0.007 (t 0.002) CPDL . Numbers in brackets denote
standard deviations of the coefficients . The F statistic associated with curve fit was 14.97, P< .001 . (B) Population-doubling time
(PDT) versus CPDL . The line fitted by the least squares method was : PDT= 2.68 (± 0.34) +0.004 (t 0.018) CPDL . F= 0.05, P<0.05 .
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FIGURE 6
￿
FBS titration curve of HUV endothelial-cell growth . HUV
endothelial cells (passage 7) were plated on a HFN matrix (10 Pg/
cm') at a seed density of 1 .25 x 103 cells/cm' . The cultures were
supplemented with various concentrations of FBS in the absence
(") and presence (x) of 100 Rg/ml ECGF . The cultures were fed
with the appropriate medium every 2-3 d for a total of 10 d . The
cells were harvested by treatment with trypsin-EDTA and the num-
ber of viable cells wascounted .
their morphological integrity, we have observed theappearance
of large and morphologically distinct, MMAGN -positive
cells . We have interpreted these giant cells to be senescent
HUV endothelial cells, as have other investigators observing
both human and bovine endothelial cells in vitro (12, 29) .
We did not observe an increase in PDT of the HUV endo-
thelial-cell cultures measured through 34 PD, although con-
fluent cell density decreased during this time . Similarly,we did
not observe a change in the concentration of extracellular
humanMILAGN from early-to late-passage HUV endothe-
lial-cell cultures . However, the strains ofHUV endothelial cells
from which these measurements were taken had not yet
achieved the end of their life spans. A more detailed study of
cellular senescence of theHUV endothelial cells may indicate
that their growth rate does decline at later stages, as does the
doubling rate in adult (29) and fetal (26) bovine aortic endo-
thelial-cell cultures. This suggestion is consistent with the ob-
servation of Rosen et al . (26) whodemonstrated that adecrease
in confluent culture density precedes a change in growth rateSERUM
FIGURE 7
￿
HUV endothelial-cell growth as a function of the con-
centration of ovine WBS, PDS, and HYPOX serum . HUVendothelial
cells (passage 9) were plated on a HFN matrix (10 tLg/cm2) at a seed
density of 1 .25 X 103 cells/cm' . The cultures were supplemented
with the following reagents : increasing concentrations of ovine
(PDS) in the absence (X) and presence of 100 FLg/ml ECGF ("),
ovine HYPOX WBS in the absence (O) and presence (0) of 1001Lg/
ml ECGF, and ovine normal WBS in the absence (1P and presence
(O) of 100 !Lg/ml ECGF . The cultures were harvested on day 10 of
the growth assay, at which time the HUV endothelial-cell number
was determined .
in bovine fetal aortic endothelial cells .
The absence of HUV endothelial-cell growth at cell-seed-
densities of - 103 cells/cm2 in the presence of FBS without
ECGF and the appearance ofmoderate endothelial-cell growth
with ECGF suggest that ECGF is required for the growth and
survival ofHUV endothelial cells . In contrast, HUV endothe-
lial cells at seed densities < 10 3 cells/cm2 did not survive and
grow in FBS- and ECGF-supplemented medium . These results
suggest the requirement of attachment factor(s) for cell survival
and growth at very low cell-seed-densities . We have identified
one such attachment factor as plasma-derivedHFN . Treatment
of the cell culture dish with 10 fag/cm2 HFN enabled HUV
endothelial cells to plate with optimum efficiency . Although
HFN is present in serum (15), the concentration ofbiologically
active HFN is probably very low because coating the surface
of the cell culture dish with serum does not abolish the HFN
requirement for low cell-density HUV endothelial-cell attach-
ment . Excellent HUV endothelial-cell growth, independent of
seed density, was achieved in cultures supplemented with FBS
and ECGF on an HFN matrix . On the other hand, only
moderate HUV endothelial-cell growth was obtained at seed
densities > 103 cells/cm 2 on HFN-coated cell culture dishes
supplemented with FBS without ECGF . These data suggest
that ECGF significantly contributes to HUV endothelial-cell
growth and survival on an HFN matrix. Furthermore, these
data are consistent with our ability to achieve serial propaga-
tion of the HUV endothelial cell in vitro .
The advantage of using an HFN matrix for HUV endothe-
lial-cell growth in serum-supplemented medium containing
ECGF is highlighted by the ability of such a culture system to
support the growth of HUV endothelial cells at clonal seed
densities (125-1.25 cells/cm') . The observation that HUV en-
dothelial cells failed to survive and grow at clonal seed densities
in ECGF- and FBS-supplemented cultures lacking a HFN
matrix suggests that ECGF was not acting as an attachment
factor for HUV endothelial cells . These results are consistent
with the observation that ECGF can stimulate the growth of
relatively quiescent low-seed-density (10 3 cells/cm') HUV en-
dothelial-cell populations (20).
The failure to achieve multiple passages of the HUV endo-
thelial-cell colonies may be due either to a finite limit on the
number of endothelial-cell PD or to the lack of additional
factors required for HUV endothelial-cell survival and growth
at very low seed densities . It is of interest that we have been
able to routinely observe, by phase-contrast microscopy, HUV
endothelial-cell colonies ofvarious sizes suggesting that growth
rates differ between individual colonies .
Numerous investigators have shown that serum supplies
hormones and growth factors for mammalian cell growth in
vitro (13, 17) . The use ofECGF in low-density HUV endothe-
lial-cell culture significantly reduced the FBS requirement for
endothelial-cell growth suggesting that ECGF is acting in
concert with existing hormones and growth factors present in
FBS . The ability of ovineHYPOX serum andECGF to support
HUV endothelial-cell growth suggests that the pituitary-de-
rived hormones do not significantly contribute to the HUV
endothelial-cell growth-promoting capabilities of serum . These
results are in agreement with the observation that substantial
in vivo vascular endothelial-cell regrowth occurs in balloon-
deendothelialized HYPOX rats (33) . Similarly, the achieve-
ment ofHUV endothelial-cell growth in either ovine PDS or
HYPOX-PDS supplemented with ECGF and confirms other
observations that platelet-derived growth factors are not re-
quired for endothelial cell growth (32, 34) . Because HUV
endothelial cells grew as a function of the concentration of
either ovine PDS or HYPOX serum in the presence ofECGF,
it is likely that (a) the hormones and growth factors that are
supplied by serum for HUV endothelial-cell growth are com-
mon to FBS, ovine PDS, and HYPOX serum, and (b) the
hormone components present in serum that are required by
HUV endothelial cells for growth act in a synergistic manner
with ECGF . The latter suggestion is consistent with the dem-
onstration of hormonal synergy in a wide variety ofmamma-
lian cell culture systems grown in a serum-free, hormonally-
defined environment (2, 21, 25) .
The requirements for the in vitro growth ofHUV endothelial
cells appear to be different from the requirements for the
vascular smooth-muscle cells . We have previously demon-
strated that the vascular smooth-muscle cell requires platelet-
derived growth factor and the somatomedins, insulin-like
growth factor-I (24) and multiplication-stimulating activity (4)
for optimal growth in a serum-free environment (36) . Because
the vascular smooth-muscle cell does not proliferate inHYPOX
rats after in vivo balloon deendothelialization (33) and prolif-
erates poorly in vitro in the presence ofHYPOX-PDS (Maciag,
T . and R . Weinstein, unpublished observation), the use of
HYPOX-PDS may be valuable in the control of smooth-mus-
cle-cell growth, a troublesome contaminant in vascular endo-
thelial-cell culture .
Because ECGF and HFN permit the long-term cultivation
of HUV endothelial cells and reduce the serum requirement
for low-seed-density growth, one can presently study the bio-
logical effects of human endothelial cell-responsive hormones
on human endothelial-cell growth and function . Further re-
finement of this system promises to facilitate the development
of a completely defined serum-free system for the cultivation
of human endothelial cells and lead to an understanding of
those hormones responsible forhuman endothelial-cell growth .
Although we have limited our approach to a study of human
endothelial-cell-culture systems, the application of these results
to endothelial cells from other species should be encouraged.
The authors express their gratitude to the following investigators : Dr .
M . A . Gimbrone for a source of primary HUV endothelial cells, Dr . L .
Hoyer for kindly performing the human factor VIIIAntigen radioim-
munoassay, and Dr. R. Bergland for the ovine normal and HYPOX
MACIAG ET AL
￿
Human Endothelial Cell Growth In Vitro
￿
425
2 .0 0 0
w 0 m
z 1.0
0
U W
0 5 10 15 20whole blood . We also wish to thank Drs . R. Rosenberg and M. A.
Gimbrone for a critical evaluation ofthe manuscriptandLiane Sanford
for preparation of the manuscript .
Receivedforpublication 15 December 1980, and in revisedform 7 July
1981 .
REFERENCES
I . Booyse, F. M., B. J. Sedlak, and M . E. Rafelson, Jr. 1975. Culture of arterial endothelial
cells: characterization and growth of bovine aortic cells . Thromb . Diath. Haemorrh . 34 :
825-839.
2. Bottenstein, J ., 1 . Hayashi, S . Hutchings, H . Masui, J . Mather, D. McClure, S. Ohasa, A.
Rizzino, G . H. Sato, G. Serrero, R. Wolfe, and R . Wit. 1978 . Serum-free media . In
Methods in Enzymology, Vol 58, S. P . Colowick and N . O . Kaplan, editors . Academic
Press, Inc ., N. Y. 94-109.
3 . Brendel, K ., E. Meezan, and E . C . Carlson. 1974 . Isolated brain microvessels: a purified
metabolically active preparation from bovine cerebral cortex. Science (Wash. D. C.). 185:
953-955.
4. Dulak, N . C., and H . M . Temin . 1973 . Multiplication stimulating activity for chicken
embryo fibroblasts from rat liver cell conditionedmedium : A family ofsmallpolypeptides .
J. Cell . Physiol. 81:161-170.
5 . Duthu, G . S., and J . R . Smith . 1980. In vitro proliferation and lifespan of bovine aorta
endothelial cells: effects of culture conditions and fibroblast growth factor . J. Cell Physiol.
103:385-392.
6. Engvall, E ., and E. Ruoslahti . 1977 . Binding of solubleform of fibroblast surface protein,
fibronectin, to collagen. Int. J. Cancer. 20 :1-5 .
7 . Gilchrest, B . A ., R. E. Nemore, and T. Maciag. 1980 . Growth ofhuman keratinocytes on
fibronectin-coated plates. Cell Biol . Int . Rep . 4:1009-1016.
8 . Gimbrone,M. A., Jr., R . S . Cotran, and J. Folkman . 1974 . Human vascular endothelial
cells : growth and DNA synthesis. J. Cell Biol. 60:673-684.
9. Gimbrone, M. A ., Jr . 1976 . Culture ofvascular endothelium . Prog. Hemostasis Thromb.
3:1-28.
10. Gospodarowicz, D ., H . Bialecki, and G . Greenburg . 1978 . Purification of the fibroblast
growth factor activity from bovine brain . J. Biol. Chem. 253:3736-3743 .
I I . Gospodarowicz, D., G. Greenburg, H . Bialecki, and B . R . Zetter. 1978 . Factors involved
in the modulation of cell proliferation in vivo and in vitro : the role of fibroblast and
epidermal growth factors in the proliferative response of mammalian cells . In Vitro . 14:
85-118 .
12. Haudenschild, C . C ., R . S. Cotran, M . A . Gimbrone, Jr., and J. Folkman . 1975 . Fine
structure ofvascular endothelium in culture . J. Ultrastruc . Res. 50 :22-32 .
13 . Hayashi, L, and G. H. Sato . 1976 . Replacemen t ofserum by hormones permits growth of
cells in a defined medium. Nature (Loud.) . 259:132-134.
14. Hayes, L. W ., C . A. Goguen, S . F . Ching, and L . L . Slakey . 1978. Angiotensin-converting
enzyme : accumulation in medium from cultured endothelial cells . Biochem . Biophys. Res.
Comm . 82:1147-1153.
15 . Hayman, E . G ., and E . Ruoslahti. 1979. Distribution of fetal bovine serum fibronectin
426
￿
THE JOURNAL OF CELL BIOLOGY " VOLUME 91, 1981
and endogenous rat cell fibronectin in extracellular matrix . J, Cell Biol . 83:255-259.
16 . Hoyer, L .W. 1972. Immunologic studies ofantihemophilic factor (AHF, factor VIII). IV .
Radioimmunoassay of AHF antigen . J. Lab . Clin. Med. 80:822-833 .
17 . Hutchings, S . E ., and G. H . Sato 1978 . Growth and maintenance ofHeLa cells ina serum-
free medium supplemented with hormones . Proc. Nail . Acad. Sci. U. S. A . 75:901-904 .
18. Jaffe, E . A., R . L . Nachman, C. G . Becker, and C . R. Minick . 1973 . Culture of human
endothelial cells derived from umbilical veins: identification by morphologic and immu-
nologic criteria . J. Clin . Invest . 52:2745-2756.
19. Johnson, A. R. 1980 . Human pulmonary endothelial cells in culture : activities of cells
from arteries and cells from veins. J. Clin. Invest. 65:841-850 .
20. Maciag, T ., J. Cerundolo, S. Ilsley, P . R . Kelley, and R . Forand . 1979 . An endothelial cell
growth factor frombovine hypothalamus: identification and partial characterization . Proc .
Nail. Acad . Sci. U. S. A . 76:5674-5678 .
21 . Maciag, T., B . Kelley, J . Cerundolo, S. Ilsley, P. R . Kelley, J . Gaudreau, and R. Forand .
1980. Hormonal requirements ofbaby hamster kidney cells in culture . Cell Biol. Int . Rep .
4:43-50 .
22. Mueller, S. N ., E . M . Rosen, and E . M . Levine . 1980. Cellular senescence in a cloned
strain ofbovine fetal aortic endothelial cells . Science, (Wash. D. C .) . 207:889-891 .
23 . Rheinwald, J. G., and H . Green . 1979 . Epidermal growth factor and multiplication of
cultured human epidermal keratinocytes. Nature (Loud.). 265:421-424 .
24. Rinderknecht, E., and R. E. Humbel . 1976. Amino-termina l sequencesoftwo polypeptides
from human serum with nonsuppressible insulin-like and cell growth-promoting activities.
Proc. Nail . Acad. Sci . U. S. A . 73:4379-4381 .
25 . Rizzino, A . and G. H. Sato. 1978 . Growth of embryonal carcinoma cells in serum-free
medium. Proc. Nail. Acad. Sci. U. S. A. 75:1844-1848 .
26. Rosen, E. M ., S . N. Mueller, J . P. Noveral, and E. M . Levine . 1981 . Proliferative
characteristics of clonal endothelial cell strains. J. Cell . Physiol. 107:123-137 .
27. Ross, R ., C . Nist, B . Kariya, M . J. Rivest, E. Raines, and J . Callis . 1978. Physiological
quiescence in plasma-derived serum: influence of platelet-derived growth factor on cell
growth in culture . J. Cell. Physiol . 97:497-508.
28 . Ryan, U . S ., E . Clements, P. Hableston, D ., and J .W. Ryan . 1978 . Isolation and culture
of pulmonary artery endothelial cells . Tissue Cell . 10:535-554.
29 . Schwartz, S . M . 1978 . Selection and characterization of bovine aortic endothelial cells. In
Vitro . 14:966-980 .
30 . Sherer, G . K ., T . P. Fitzharris, W . P . Faulk, and E . C . LeRoy. 1980 . Cultivation of
microvascular endothelial cells fromhuman preputial skin . In Vitro 16:675-684.
31 . Slater, D . N., and 1 . M . Sloan . 1975. The porcine endothelial cell in tissue culture.
Atherosclerosis . 21:259-272.
32 . Thorgiersson, G ., and A . L. Robertson, Jr. 1978 . Platelet factors and the human vascular
wall, Part 2: Such factors are not required for endothelial cell proliferatin and migration.
Atherosclerosis . 31:231-238 .
33 . Tiell, M . L., M . B. Stemerman, and T. H. Spaet. 1978. The influence ofthe pituitary on
arterial intimal proliferation in the rat . Circ . Res. 42:644-649 .
34. Wall, R . T ., L . A . Harker, L. 1 . Quadracci, and G . E. Striker. 1978 . Factors influencing
endothelial cell proliferation in vitro. J. Cell. Physiol. 96:203-214 .
35 . Weinstein, R ., M. B. Stemerman, E . D . MacIntyre, H . N . Steinberg, and T . Maciag. 1981 .
The morphological and biochemical characterization ofa line of rat promegakaryoblasts.
Blood. 58:110-121 .
36 . Weinstein, R ., M . B. Stemerman, andT . Maciag. 1981 . Hormonalrequirements for growth
of arterial smoothmuscle cells in vitro : an endocrine approach to atherosclerosis . Science
(Wash. D. C.). 212:818-820.